The invention also discloses application of CDK7 targeting inhibitor in preparation of drugs for treating cytokine release syndrome
A technology of cytokines and inhibitors, applied in the field of preparation of drugs for the treatment of cytokine release syndrome, capable of solving problems such as different limitations or side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1: Comparative experiments on the inhibition of CDK-7-targeting small molecule drugs of THZ1, SY-1365, and BS-181 on related target molecules in an inflammation model
[0031] Monocytes (THP-1, human monocytic cell line) in the exponential growth phase were treated with 100ng / ml PMA for 24 hours to form macrophages (mTHP-1, human monocyte-induced macrophages), and then respectively Treat the 500ng / ml LPS-induced inflammation model with 30nM THZ1, 30nM SY-1365, 10μM BS-181, collect the cells, and perform western detection of related proteins. The results are as follows image 3 As shown, THZ1, SY-1365, and BS-181 all have the effect of inhibiting LPS-induced inflammation (see image 3 A), THZ1-CDK7, SY-1365-CDK7, and BS-181-CDK7 complexes all have a certain inhibitory effect on RNA Poly II2, 7 site serine phosphorylation (see image 3 B1); To sum up, THZ1 has the best anti-inflammatory effect.
Embodiment 2
[0032] Example 2: THZ1 targets CDK7-RNA Polymerase II complex to regulate gene transcription and western experiments
[0033] Monocytes in the exponential growth phase were treated with 100ng / ml PMA for 24 hours to form macrophages, then treated with different concentrations of THZ1 (0, 20, 40, 100, 200nM) for 30 minutes, and then collected at different time points (8, 24 hours), the cells were collected, and western detection of related proteins was carried out. Figure 4 Schematic diagram of THZ1 targeting CDK7-RNA Polymerase II complex to regulate gene transcription. Among them, A represents the schematic diagram of RNA Poly, the mRNA transcription complex that THZ1 targets and regulates CDK7; B represents the effect of THZ1-CDK7 complex on RNAPoly II2, 7-site serine phosphorylation in western experiments under different concentrations and different action times of THZ1. Inhibition of chemicalization: As time goes by, the inhibitory effect weakens; the inhibitory effect in...
Embodiment 3
[0034] Example 3: Bacterial infection model of THZ1 targeting CDK7-RNA Polymerase II complex
[0035] Figure 5 It is the qRT-PCR experiment result of the bacterial infection model in which THZ1 targets CDK7-RNA Polymerase II complex, among which, A shows that THZ1 can significantly inhibit interleukin IL1B, interleukin Expression of IL6, interleukin IL8, tumor necrosis factor TNFA and chemokine CXCL10 and other related inflammatory genes; B shows that THZ1 can significantly inhibit interleukin IL1B, interleukin Expression of IL6, interleukin IL8, tumor necrosis factor TNFA and chemokine CXCL10 and other related inflammatory genes; C shows that THZ1 can significantly inhibit interleukin IL1B in HFF-1 (skin fibroblasts) , interleukin IL6, interleukin IL8, tumor necrosis factor TNFA and chemokine CXCL10 and other related inflammatory gene expression; D shows that THZ1 can significantly inhibit leukocyte-mediated Expression of IL1B, interleukin IL6, interleukin IL8, tumor necro...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com